Objective:

To understand the role of regulatory T cells in the transition from ductal carcinoma in situ (DCIS) to invasive breast cancer.

Key Findings:

• Cycling Tregs expand rapidly during the transition from DCIS to invasive breast cancer, suppressing immune activity.
• Reducing cycling Tregs in animal models increased immune activity and slowed tumor development.
• Cycling Tregs are present in human DCIS and invasive breast cancer, correlating with higher grade disease and poor outcomes.

Interpretation:

The study suggests that targeting cycling Tregs could be a potential strategy to prevent the progression of DCIS to invasive breast cancer, although precise targeting mechanisms are still needed.

Limitations:

• Current targeting of cycling Tregs is not clinically viable.
• Further research is needed to identify triggers for Treg expansion.

Conclusion:

Understanding the role of cycling Tregs in breast cancer progression may lead to new therapeutic strategies to prevent invasive disease.